Since hepatic expression of DPP4 is associated with NAFLD [6], we examined whether OMG improves liver function as well as levels of inflammation and insulin resistance in type 2 diabetic patients with NAFLD. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.